Banner

HPV Associated Disorders Global Market Report 2023 – By Indication (Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Other Indications), By Therapy (Prevention, Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The human papillomavirus-associated disorders refer to a virus that can induce aberrant tissue growth such as warts and other cell abnormalities. These disorders are mainly transmitted by sexual intercourse or other forms of skin-to-skin contact. Vaccines, medication, and other diagnoses can help protect against HPV types that cure HPV cancer.

The main indication of HPV associated disorders are cervical intraepithelial neoplasia (CIN), cervical cancer, anal intraepithelial neoplasia (AIN), anal cancer, genital warts, and others indication. The cervical intraepithelial indication of HPV associated disorder are are used for the prevention and treatment of cervical intraepithelial neoplasia. Cervical intraepithelial neoplasia (CIN) refers to abnormal alterations in the cells that line the cervix. The therapy of HPV associated disorders are prevention and treatment which are provided by hospital pharmacies, retail pharmacies and online pharmacies.

The HPV associated disorders market research report is one of a series of new reports from The Business Research Company that provides HPV associated disorders market statistics, including HPV associated disorders industry global market size, regional shares, competitors with a HPV associated disorders market share, detailed HPV associated disorders market segments, market trends and opportunities, and any further data you may need to thrive in the HPV associated disorders industry. This HPV associated disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global hpv associated disorders market size grew from $17.82 billion in 2022 to $19.07 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hpv associated disorders market size is expected to grow to $24.77 billion in 2027 at a CAGR of 6.7%.

Increased prevalence of HPV-related cases is expected to propel the HPV-associated disorders market. HPV-associated disorders include benign verrucae vulgares, condylomata acuminata to the malignancies of the cervix, vulva, anus, and penis, anogenital warts, recurrent respiratory papillomatosis, anogenital and oropharyngeal cancers. HPV infection has a considerable proportion worldwide, mainly in women. For instance, In January 2022, In 2020, according to a report published by cancer.net, an estimated 14,100 women in the United States will be diagnosed with invasive cervical cancer, with 604,127 women worldwide diagnosed with cervical cancer. Furthermore, In 2020, an estimated 341,831 women died from cervical cancer worldwide. Therefore, an increase in the prevalence of HPV cases will drive the HPV-associated disorders market.

Targeted therapies are a key trend gaining popularity in HPV-associated disorders. Major players are developing and adopting targeted therapies for treating HPV-associated disorders such as cervical cancer, oropharyngeal cancer, and others. Targeted therapies include drugs that target vascular endothelial growth factor protein and tissue-factor (TF) protein on cancer cells and others. For instance, in September 2021, FDA approved Genmab A/S and Seagen Inc., drug Tivdak (tisotumab vedotin-tftv) for recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Thus, emerging targeted therapies will treat HPV-associated disorders effectively.

In May 2022, GlaxoSmithKline plc, a UK-based biopharma company acquired, Affinivax, Inc for $2.1 billion. Through this acquisition, GSK plc strengthens its vaccine R&D pipeline and provides access to a new technology MAPS (Multiple Antigen Presenting System). Affinivax, Inc is a US-based clinical stage biopharmaceutical company that provides next-generation vaccine technology platforms for the development of vaccines.

Major players in the hpv associated disorders market are AstraZeneca plc, F. Hoffmann-La Roche Ltd., Biocon Ltd., GlaxoSmithKline plc, Merck & Co. Inc., Eli Lilly and Company, Cytovation AS, Pfizer Inc., Amgen Inc., Johnson & Johnson Services Inc., Advaxis Inc., Kino Pharma Inc., Serum Institute, Inovio Pharmaceuticals and PapiVax Biotech Inc.,

North America was the largest region in the HPV associated disorders market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the HPV associated disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the HPV associated disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The human papillomavirus-associated disorders market includes revenues earned by entities by plantar warts and flat warts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global hpv associated disorders market is segmented -

1) By Indication: Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Other Indications

2) By Therapy: Prevention, Treatment

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    Table Of Contents

    1. Executive Summary

    2. HPV Associated Disorders Market Characteristics

    3. HPV Associated Disorders Market Trends And Strategies

    4. HPV Associated Disorders Market - Macro Economic Scenario

    4.1. COVID-19 Impact On HPV Associated Disorders Market

    4.2. Ukraine-Russia War Impact On HPV Associated Disorders Market

    4.3. Impact Of High Inflation On HPV Associated Disorders Market

    5. HPV Associated Disorders Market Size And Growth

    5.1. Global HPV Associated Disorders Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global HPV Associated Disorders Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. HPV Associated Disorders Market Segmentation

    6.1. Global HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Cervical Intraepithelial Neoplasia (CIN)

    Cervical Cancer

    Anal Intraepithelial Neoplasia (AIN)

    Anal Cancer

    Genital Warts

    Other Indications

    6.2. Global HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Prevention

    Treatment

    6.3. Global HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. HPV Associated Disorders Market Regional And Country Analysis

    7.1. Global HPV Associated Disorders Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global HPV Associated Disorders Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific HPV Associated Disorders Market

    8.1. Asia-Pacific HPV Associated Disorders Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China HPV Associated Disorders Market

    9.1. China HPV Associated Disorders Market Overview

    9.2. China HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India HPV Associated Disorders Market

    10.1. India HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan HPV Associated Disorders Market

    11.1. Japan HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia HPV Associated Disorders Market

    12.1. Australia HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia HPV Associated Disorders Market

    13.1. Indonesia HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea HPV Associated Disorders Market

    14.1. South Korea HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe HPV Associated Disorders Market

    15.1. Western Europe HPV Associated Disorders Market Overview

    15.2. Western Europe HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK HPV Associated Disorders Market

    16.1. UK HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany HPV Associated Disorders Market

    17.1. Germany HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France HPV Associated Disorders Market

    18.4. France HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe HPV Associated Disorders Market

    19.1. Eastern Europe HPV Associated Disorders Market Overview

    19.2. Eastern Europe HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia HPV Associated Disorders Market

    20.1. Russia HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America HPV Associated Disorders Market

    21.1. North America HPV Associated Disorders Market Overview

    21.2. North America HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA HPV Associated Disorders Market

    22.1. USA HPV Associated Disorders Market Overview

    22.2. USA HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America HPV Associated Disorders Market

    23.1. South America HPV Associated Disorders Market Overview

    23.2. South America HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil HPV Associated Disorders Market

    24.1. Brazil HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East HPV Associated Disorders Market

    25.1. Middle East HPV Associated Disorders Market Overview

    25.2. Middle East HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa HPV Associated Disorders Market

    26.1. Africa HPV Associated Disorders Market Overview

    26.2. Africa HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. HPV Associated Disorders Market Competitive Landscape And Company Profiles

    27.1. HPV Associated Disorders Market Competitive Landscape

    27.2. HPV Associated Disorders Market Company Profiles

    27.2.1. AstraZeneca plc

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. F. Hoffmann-La Roche Ltd

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Biocon Ltd

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. GlaxoSmithKline plc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Merck & Co. Inc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The HPV Associated Disorders Market

    29. HPV Associated Disorders Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global HPV Associated Disorders Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global HPV Associated Disorders Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: AstraZeneca plc Financial Performance
  • Table 47: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 48: Biocon Ltd Financial Performance
  • Table 49: GlaxoSmithKline plc Financial Performance
  • Table 50: Merck & Co. Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global HPV Associated Disorders Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global HPV Associated Disorders Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global HPV Associated Disorders Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, HPV Associated Disorders Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, HPV Associated Disorders Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: AstraZeneca plc Financial Performance
  • Figure 47: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 48: Biocon Ltd Financial Performance
  • Figure 49: GlaxoSmithKline plc Financial Performance
  • Figure 50: Merck & Co. Inc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report